NYSE:GEN - Genesis Healthcare Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$1.56 -0.10 (-6.02 %)
(As of 12/14/2018 04:00 PM ET)
Previous Close$1.66
Today's Range$1.52 - $1.66
52-Week Range$0.67 - $2.86
Volume215,166 shs
Average Volume247,478 shs
Market Capitalization$273.24 million
P/E Ratio-0.74
Dividend YieldN/A
Beta0.42

Analyst Ratings

Genesis Healthcare (NYSE:GEN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Genesis Healthcare in the last 12 months. Their average twelve-month price target is $3.3125, suggesting that the stock has a possible upside of 112.34%. The high price target for GEN is $7.00 and the low price target for GEN is $1.75. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldHoldHold
Consensus Rating Score: 2.502.252.332.25
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $3.3125$3.1875$3.6667$2.00
Price Target Upside: 112.34% upside89.73% upside141.23% upside42.86% upside

Genesis Healthcare (NYSE:GEN) Consensus Price Target History

Price Target History for Genesis Healthcare (NYSE:GEN)

Genesis Healthcare (NYSE:GEN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/28/2018Stifel NicolausUpgradeHold ➝ Buy$2.00 ➝ $2.50HighView Rating Details
11/7/2018Cantor FitzgeraldReiterated RatingBuy$7.00HighView Rating Details
10/16/2018Credit Suisse GroupInitiated CoverageNeutral$1.75LowView Rating Details
3/19/2018StephensReiterated RatingHold$2.00HighView Rating Details
9/13/2017Royal Bank of CanadaReiterated RatingHold$2.00LowView Rating Details
(Data available from 12/14/2016 forward)
This page was last updated on 12/14/2018 by MarketBeat.com Staff

Featured Article: Dividend Aristocrat Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel